Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...
Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...
An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.
A great Dopp kit will keep your grooming essentials organized once you reach your destination and prevent them from leaking in your bag while you’re in transit. It must be waterproof (or at ...
We reviewed the best free Adobe Illustrator alternatives for managing graphics files without a Creative Cloud subscription. We've rounded-up our top-rated choices for when you want to make the ...
By providing customers with a costeffective and accessible solution for a wider choice of serotypes, the kits support tailored approaches to gene therapy development, delivering unmatched precision ...
Amid fresh controversy over the Board of Control for Cricket in India's alleged refusal to have 'Pakistan' printed on the team's Champions Trophy kits as part of the tournament logo, the Indian ...
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...
A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...
Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...
New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality HERCULES, Calif. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results